Stock Split History
ETFs Holding CDXC »    CDXC Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ChromaDex is a global bioscience company dedicated to healthy aging. Co. is also a provider of research and quality-control products and services to the natural products and life science industries. Co. provides its NIAGEN® NR through its TRU NIAGEN® finished bottles and TRU NIAGEN® Stickpacks. Co. develops and sells NIAGEN® in ingredient form to partners. IMMULINA® is a spirulina extract and the predominant active compounds are Braun-type lipoproteins which are useful for supporting human immune function. In addition, Co. supplies a range of products necessary to conduct quality control of raw materials and consumer products. According to our ChromaDex stock split history records, ChromaDex has had 1 split.
ChromaDex stock split history picture
ChromaDex (CDXC) has 1 split in our ChromaDex stock split history database. The split for CDXC took place on April 13, 2016. This was a 1 for 3 reverse split, meaning for each 3 shares of CDXC owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 333.333333333333 share position following the split.

When a company such as ChromaDex conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the ChromaDex stock split history from start to finish, an original position size of 1000 shares would have turned into 333.333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into ChromaDex shares, starting with a $10,000 purchase of CDXC, presented on a split-history-adjusted basis factoring in the complete ChromaDex stock split history. ChromaDex split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 09/26/2012
End date: 09/23/2022
Start price/share: $2.49
End price/share: $1.21
Dividends collected/share: $0.00
Total return: -51.41%
Average Annual Total Return: -6.96%
Starting investment: $10,000.00
Ending investment: $4,861.64
Years: 10.00
Date Ratio
04/13/20161 for 3
CDXC is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

CELG Split History
CERE Split History
CERU Split History
CFRX Split History
CGIX Split History
CGNT Split History
CHDX Split History
CHE Split History
CHFS Split History
CHRS Split History

Also explore: CDXC shares outstanding history

Email EnvelopeFree CDXC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Annaly Capital Management, Inc. (NLY)
CohBar, Inc. (CWBR)
TOP Ships Inc. (TOPS)
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Nabriva Therapeutics plc (NBRV)
NeuroBo Pharmaceuticals, Inc. (NRBO)
First Wave BioPharma, Inc. (FWBI)
Palatin Technologies, Inc. (PTIN)
TD Holdings, Inc. (GLG )
Iterum Therapeutics plc (ITRM)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding ChromaDex
ChromaDex Insider Buying

ChromaDex Stock Split History | www.StockSplitHistory.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.StockSplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.